These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2. Rosenson RS; Stafforini DM J Lipid Res; 2012 Sep; 53(9):1767-82. PubMed ID: 22665167 [TBL] [Abstract][Full Text] [Related]
7. Lipoprotein-associated phospholipase A2: a potential therapeutic target for atherosclerosis. Zalewski A; Macphee C; Nelson JJ Curr Drug Targets Cardiovasc Haematol Disord; 2005 Dec; 5(6):527-32. PubMed ID: 16503872 [TBL] [Abstract][Full Text] [Related]
8. The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma. Tellis CC; Tselepis AD Biochim Biophys Acta; 2009 May; 1791(5):327-38. PubMed ID: 19272461 [TBL] [Abstract][Full Text] [Related]
9. Lipoprotein-associated phospholipase A2 as a target of therapy. Macphee CH; Nelson JJ; Zalewski A Curr Opin Lipidol; 2005 Aug; 16(4):442-6. PubMed ID: 15990594 [TBL] [Abstract][Full Text] [Related]
13. Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia. Karabina SA; Elisaf M; Bairaktari E; Tzallas C; Siamopoulos KC; Tselepis AD Eur J Clin Invest; 1997 Jul; 27(7):595-602. PubMed ID: 9263748 [TBL] [Abstract][Full Text] [Related]
14. Extracellular phospholipases in atherosclerosis. Karabina SA; Gora S; Atout R; Ninio E Biochimie; 2010 Jun; 92(6):594-600. PubMed ID: 20153800 [TBL] [Abstract][Full Text] [Related]
15. Functional impairment of two novel mutations detected in lipoprotein-associated phospholipase A2 (Lp-PLA2) deficiency patients. Ishihara M; Iwasaki T; Nagano M; Ishii J; Takano M; Kujiraoka T; Tsuji M; Hattori H; Emi M J Hum Genet; 2004; 49(6):302-307. PubMed ID: 15148590 [TBL] [Abstract][Full Text] [Related]
16. Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke. Caslake MJ; Packard CJ Nat Clin Pract Cardiovasc Med; 2005 Oct; 2(10):529-35. PubMed ID: 16186851 [TBL] [Abstract][Full Text] [Related]
17. Role of lipoprotein-associated phospholipase A2 in atherosclerosis and its potential as a therapeutic target. Macphee CH; Nelson J; Zalewski A Curr Opin Pharmacol; 2006 Apr; 6(2):154-61. PubMed ID: 16495153 [TBL] [Abstract][Full Text] [Related]
18. Lipoprotein-associated phospholipase A2: a potential new risk factor for coronary artery disease and a therapeutic target. Macphee CH Curr Opin Pharmacol; 2001 Apr; 1(2):121-5. PubMed ID: 11714085 [TBL] [Abstract][Full Text] [Related]